Cost Effectiveness of Substance Use Disorder Treatment in New Hampshire
In 2018, New Hampshire House Bill 1626 (HB 1626) was passed into law requiring cost effectiveness reports of certain substance use prevention and treatment programs. This study of Clinically Managed High Intensity Residential Treatment Services in New Hampshire was undertaken in fulfillment of this statutory requirement. Clinically Managed High Intensity Residential Treatment
Services (American Society of Addiction Medicine Level 3.5) is a treatment program type with a relatively large number of clients, serves clients with the highest level of substance use disorder acuity, and is a relatively high cost program with respect to state expenditures. Published in 2020.